Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

Clinical trial NCT01447394 · WITHDRAWN

Trial details

NCT number: NCT01447394
Sponsor: Bristol-Myers Squibb
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C Virus (HCV)

Start date: 2012-03-01
Primary completion: 2014-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.